Reader Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis
- PMID: 35288475
- DOI: 10.1212/WNL.0000000000200132
Reader Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis
Comment in
-
Author Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.Neurology. 2022 Mar 15;98(11):471. doi: 10.1212/WNL.0000000000200133. Neurology. 2022. PMID: 35288476 No abstract available.
-
Author Response: Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease.Neurology. 2022 Mar 22;98(12):515. doi: 10.1212/WNL.0000000000200162. Neurology. 2022. PMID: 35314516 No abstract available.
Comment on
-
Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.Neurology. 2021 Nov 9;97(19):e1898-e1905. doi: 10.1212/WNL.0000000000012752. Epub 2021 Sep 9. Neurology. 2021. PMID: 34504023
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical